相关实验视频
Updated: Jun 5, 2025
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
37.1K
大型抑郁症的精神药理学的最新进展
Laith Alexander1,2, Allan H Young1,3
1Department of Psychological Medicine, School of Academic Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom.
BJPsych advances
|December 9, 2024
概括
本综述涵盖了针对严重抑郁症 (MDD) 的新型精神药物治疗方法. 它检查了针对血清激素,质激素和GABAergic系统以及炎症的新兴疗法,并评估了它们的临床使用准备情况.
科学领域:
- 心理药理学 心理药理学
- 神经科学是一个神经科学.
- 临床精神病学 临床精神病学
背景情况:
- 大型抑郁症 (MDD) 仍然是一个重大的全球健康挑战,需要治疗.
- 目前用于MDD的治疗方法,主要针对血清能系统,对许多患者的疗效和耐受性有局限性.
- 了解神经生物学方面的进步为新的治疗策略提供了机会.
研究的目的:
- 审查重大抑郁障碍 (MDD) 心理药理学的最新进展.
- 综合新兴药理疗法的证据,针对关键的神经递质系统和炎症通路.
- 评估新型MDD治疗的临床准备和证据基础.
主要方法:
- 对心理药理学近期研究的系统文献综述.
- 证据综合侧重于血清激素,质激素和GABAergic系统.
- 对研究MDD的炎症标志物和点的研究进行分析.
主要成果:
- 针对神经质系统的新兴疗法比传统抗抑郁药更有前途.
- 涉及谷氨酸和GABAergic系统的新型治疗途径正在积极研究中.
- 炎症在MDD中的作用越来越被认可,正在探索抗炎策略.
- 几种新型治疗方法正在开发中,但在常规实践之前需要进一步的临床验证.
结论:
- 在开发新型精神药物治疗MDD方面取得了重大进展.
- 向谷氨酸,GABAergic和炎症途径是MDD治疗中的一个有希望的前沿.
- 进一步的研究和临床试验对于将这些进展转化为MDD患者的有效临床实践至关重要.
相关概念视频
01:23Antidepressant Drugs: MAOIs and Other Agents
194
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
194
01:25Antidepressant Drugs: Overview
357
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
357
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
303
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
303
01:28Drug Therapy
39
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
39
01:18Depression: Overview
215
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
215
01:27Depressive Disorders: Etiology
49
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
49